Intuitive Surgical stock
Price history
−19.21% over the period1 year: from $546.71 (November 17, 2025) to $441.69 (November 16, 2026), −19.21%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 16, 2026 | $441.69 |
| October 30, 2026 | $432.01 |
| September 30, 2026 | $406.63 |
| August 31, 2026 | $376.86 |
| July 31, 2026 | $353.33 |
| June 30, 2026 | $397.68 |
| May 29, 2026 | $424.64 |
| April 30, 2026 | $457.61 |
| March 31, 2026 | $460.99 |
| February 27, 2026 | $503.51 |
| January 30, 2026 | $504.22 |
| December 31, 2025 | $566.36 |
| November 28, 2025 | $573.48 |
| November 17, 2025 | $546.71 |
At a glance
The company
Develops and markets minimally invasive surgical systems including da Vinci robotic surgery platform and Ion endoluminal diagnostic system
Latest results
Quarter to September 30, 2026 · EPS $3.00 (estimate $2.64)
Next event
TickerLandia's take on Intuitive Surgical
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 56 vs a median of 73 over its last 7 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 54 vs 43 (+24%) in a group of 9.
- Strong point: Financial strength (88/100 in its group). Weak point: Market momentum (47/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−26.86% from the 52-week high
Analysts · 34 analysts
Average target$486.57+10.16% vs. price
Buy 26 · Hold 6 · Sell 2 · Buy
TickerLandia Fingerprint: Intuitive Surgical
Compared with similar companies: very high financial strength, very high price, and very high profitability.
Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 883 North American stocks.
Pricevery high84
How much it costs relative to what it produces.
Metric Value Position in group EV/EBITDA 33.5 87 Price/book 9.62 87 Price/sales 13.3 96 P/E (trailing 12 months) 53.6 72 Forward P/E 35.6 81 Profitabilityvery high81
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 31.7% 87 Gross margin 66.6% 84 Net margin 25.5% 87 ROE 17.9% 69 ROA 11.9% 78 Earnings stabilityaverage57
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 2.9% 51 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 63 Growthhigh68
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +17.39% 93 Earnings growth (year over year) −23.60% 20 Revenue growth (year over year) +21.70% 93 Financial strengthvery high88
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Current ratio 3.33 87 Net debt/EBITDAcounts in reverse: lower means more financial strength · more cash than debt −0.90 89 Dividendno dividend
How much it returns to shareholders, and for how long.
Market momentumaverage47
How the stock has moved compared with the market.
Metric Value Position in group 1-year return −21.56% 11 Relative strength (3 months) +14.02% 82 Relative strength (6 months) +1.03% 46 Distance from 200-day average +3.31% 51 Riskhigh63
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 44.0% 79 Volatility (60 days) 33.6% 48 Beta (1 year) 0.92 62
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Intuitive Surgical is cheaper than in the past and pricier than similar companies
On the latest fiscal year's earnings (2025), Intuitive Surgical's P/E today is 56.1, below the median of its last 7 fiscal years (72.7; between 51.2 and 92.8 from 2019 to 2025). Intuitive Surgical's P/E (trailing 12 months): 53.6, +24% against the median of a group of 9 similar companies (43.1).
Compared with 9 similar companies
| Metric | Intuitive Surgical | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 53.6 | Middle | |
| Forward P/E | 35.6 | High | |
| Operating margin | 31.7% | High | |
| ROE | 17.9% | High | |
| Price/book | 9.62 | High |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Intuitive Surgical. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$3.05B
Latest quarter · Q3 2026
Net income
$522.8M
Latest quarter · Q3 2026
Quarterly net margin
17.1%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $153.77B
- P/E
- 53.6
- EPS
- $8.27
- Volume
- 1.6M
- Daily trading
- €1.11B
- Dividend yield
- 0.00%
How Intuitive Surgical is changing
All resultsRevenue grew 18.2% a year on average over the last 5 years
Operating margin rose from 25.3% to 29.3%
Free cash flow equal to 65% of net income
Returns
Intuitive Surgical returns
$1,000 invested in Intuitive Surgical 5 years ago, on November 16, 2021, would be worth $1,223 today: +22.31% in total, +4.11% per year. This is the price return only: dividends are excluded.
| Period | Intuitive Surgical | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +3.51% | −3.12% | $1,035 |
| 6 months | +4.88% | +2.07% | $1,049 |
| Year to date | −22.01% | +10.46% | $780 |
| 1 year | −19.21% | +13.33% | $808 |
| 3 years | +45.32% | +67.73% | $1,453 |
| 5 years | +22.31% | +60.86% | $1,223 |
| 10 years | +517.88% | +247.35% | $6,179 |
Over the last 6 months it has done better than 28% of the stocks in the Healthcare sector.
Price only, without dividends. Calculate your investment
The chart in detail
Intuitive Surgical: technical analysis
Intuitive Surgical shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 27.6% below its all-time closing high ($610.45, January 22, 2025).
- Trend
- No clear trend
- RSI (14 sessions)
- 51
- Between 30 and 70
- vs 200-session average
- +2.94%
Support and resistance
Price areas where Intuitive Surgical has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$488.50+10.60%2 touches, last on November 4, 2026
- Resistance$458.44+3.79%2 touches, last on October 26, 2026
- Resistance$448.17+1.47%4 touches, last on July 7, 2026
- Last price$441.69
- Support$431.02−2.42%2 touches, last on October 30, 2026
- Support$417.13−5.56%2 touches, last on September 28, 2026
- Support$397.73−9.95%3 touches, last on October 21, 2026
Volatility and risk
Over the last year it has moved roughly in line with the S&P 500.
- Beta (1 year) vs S&P 500
- 0.92
- Volatility (60 sessions, annualised)
- 33.6%
- Largest fall in the last year
- −44.00%
In session, November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Intuitive Surgical: seasonality
Average monthly price change over 27 years
Over the last 27 years, the strongest month for Intuitive Surgical has been July: +8.62% on average, positive in 17 years out of 27. The weakest has been February: −1.37% on average, positive in 15 years out of 26. November, the current month, has been positive in 20 years out of 26 (+4.12% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +1.23% | +1.16% | 13 of 26 |
| February | −1.37% | +0.92% | 15 of 26 |
| March | +3.76% | +1.93% | 17 of 26 |
| April | +3.94% | +3.86% | 16 of 26 |
| May | +2.06% | +1.42% | 15 of 26 |
| June | +5.95% | +2.80% | 16 of 26 |
| July | +8.62% | +5.19% | 17 of 27 |
| August | −0.12% | −0.38% | 13 of 27 |
| September | −1.18% | −0.28% | 13 of 27 |
| October | +5.79% | +6.24% | 16 of 27 |
| November | +4.12% | +4.57% | 20 of 26 |
| December | −0.03% | −0.64% | 12 of 26 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Intuitive Surgical and its competitors
Based in Sunnyvale, California, the company has existed since its incorporation in 1995. Its core offering is the da Vinci Surgical System, used for surgical procedures through a minimally invasive approach, and the Ion endoluminal system, which extends into diagnostic procedures such as lung biopsies. It also supplies stapling, energy and core instruments for multi-port da Vinci systems, training pathways, installation, repair, maintenance and 24/7 technical support, plus connected digital services for hospitals.
- Headquarters
- Sunnyvale, United States
- Employees
- 17,021
- Founded
- 1995
- Chief executive
- David Rosa
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Intuitive SurgicalISRG | $153.77B | 31.7% | 53.6 | +4.88% |
| Becton, DickinsonBDX | $59.39B | 15.7% | 43.1 | +51.77% |
| MedlineMDLN | $51.94B | 5.4% | 89.7 | +8.01% |
| ResMedRMD | $33.69B | 34.0% | 21.8 | +19.45% |
| West Pharmaceutical ServicesWST | $29.01B | 22.9% | 46.7 | +38.61% |
| SolventumSOLV | $15.14B | 5.9% | 100.1 | +20.62% |
Same industry or related industries, similar size. Compare Intuitive Surgical with its competitors · Full profile
More on Intuitive Surgical
- Intuitive Surgical revenue and financials
- Intuitive Surgical valuation
- Intuitive Surgical stock return
- Intuitive Surgical employees, headquarters and business
